Objective There is an urgent need to assess the impact of immunosuppressive therapies on
the immunogenicity and efficacy of SARS-CoV-2 vaccination. Methods Serological and T …

Data are shown as median with IQR. Statistical analysis is by MannWhitney test (A) or
KruskallWallis test with Dunns posthoc correction (B).(A) Kidney transplant recipients who …

Background Solid organ transplant recipients have attenuated immune responses to SARS-
CoV-2 vaccines. In this study, we report on immune responses to 3rd-(V3) and 4th-(V4) …

Results A total of 1121 in-center hemodialysis patients were included in the analysis; all
patients underwent weekly screening for SARS-CoV-2 infection via reverse transcriptase …

Background People with end-stage kidney disease, including people on haemodialysis, are
susceptible to greater COVID-19 related morbidity and mortality. This study compares the …

Background Dialysis patients are at risk of severe coronavirus disease 2019 (COVID-19).
We managed COVID-19 hemodialysis outpatients in dedicated satellite dialysis units. This …

Background Attenuated immune responses to mRNA SARS-CoV-2 vaccines have been
reported in solid organ transplant recipients. Most studies have assessed serological …

Background Limited data exists on the immunogenicity of vector-based SARS-CoV-2
vaccines in patients with kidney disease. Given their use in over 180 countries, such data is …

Background: Lateral flow immunoassays (LFIAs) are able to achieve affordable, large scale
antibody testing and provide rapid results without the support of central laboratories. As part …

We aimed to describe the outcomes of Omicron infection in kidney transplant recipients
(KTR), compare the efficacy of the community therapeutic interventions and report the safety …